PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review)

Publisher： Spandidos Publications

E-ISSN： 1791-244X|35|1|10-16

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.35, Iss.1, 2015-01, pp. : 10-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC

By  

CLINICAL OTOLARYNGOLOGY, Vol. 40, Iss. 6, 2015-12 ,pp. : 622-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Dark Side of the Moon: The PI3K/PTEN/AKT Pathway in Colorectal Carcinoma

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 69-74

Karger

Access to resources Recommend Favorite

Clinical Significance of Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway in Korean Patients with Colorectal Cancer

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 278-282

Karger

Access to resources Recommend Favorite

The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)

By  

Current Signal Transduction Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 246-256

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/AKT pathway activation in bladder carcinogenesis

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : 1776-1784

John Wiley & Sons Inc

Access to resources Recommend Favorite